Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma
Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma have?
Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma has 51 citations in the OpenAlex counts ScholarIQ stores.
When was Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma published?
Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma has 2020 year in the ScholarIQ index.
What is the open-access status of Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma?
Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma has closed oa status in the ScholarIQ index.
What is the DOI of Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma?
The DOI for Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma is on the source record.
What is the PMID of Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma?
The PMID for Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma is on the source record.
What is the OpenAlex record for Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma?
The OpenAlex for Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma is on the source record.